Saudubray J M, Touati G, Delonlay P, Jouvet P, Narcy C, Laurent J, Rabier D, Kamoun P, Jan D, Revillon Y
Department of Paediatrics, Hopital Necker Enfants-Malades, 149 rue de Sevres, 75743 Paris, France.
Eur J Pediatr. 1999 Dec;158 Suppl 2:S55-9. doi: 10.1007/pl00014323.
We report here our experience in the long-term management of 28 patients with citrullinaemia, 13 patients with carbamoyl phosphate synthase deficiency and 15 patients with argininosuccinic aciduria. In addition, we report a national French survey of 119 patients with ornithine transcarbamylase (OTC) deficiency enzymatically characterized in our laboratory. We also include in this report four personal patients (two with OTC and two with citrullinaemia) who were liver transplanted, and one OTC patient from the National French survey. Although this retrospective series is not really representative of the modern treatment combining low protein diet and arginine, sodium benzoate and sodium phenylbutyrate, it is obvious that the long-term outcome of all urea cycle disorders remains very guarded. We highlight the severity of the neonatal forms of such disorders, and mostly for OTC-deficient males. According to this evidence, our policy is not to treat such severely affected patients in the neonatal period who die anyway spontaneously within 2 to 3 days. At the present time, we only have three patients with neonatal citrullinaemia, aged 1, 6 and 10 years respectively, who are still doing well. One of them has been successfully liver transplanted at 5 years. Another transplanted patient died in the post-surgical phase. We emphasize the unexpected severity of argininosuccinic aciduria in which there is no one patient doing well. This is a rather surprising finding as this disorder is easy to manage and rarely presents with recurrent attacks of hyperammonaemia when it is treated by arginine supplementation. This consideration would suggest to extend the indication of orthotopic liver transplantation in this disorder. Finally, the most difficult indication is in the late onset symptomatic female OTC group. In this last group, despite a significant residual activity due to heterozygote status, even with a variable lyonisation, only seven girls are still mentally and neurologically normal. Interestingly, three of these seven were liver-transplanted before the constitution of irreversible neurological damage. These three girls and their family declare their well-being, their feeling to be cured and enjoy their normal life.
我们在此报告对28例瓜氨酸血症患者、13例氨甲酰磷酸合成酶缺乏症患者和15例精氨琥珀酸尿症患者进行长期管理的经验。此外,我们报告了一项法国全国性调查,涉及在我们实验室进行酶学特征分析的119例鸟氨酸转氨甲酰酶(OTC)缺乏症患者。本报告还纳入了4例接受肝移植的个人患者(2例OTC缺乏症患者和2例瓜氨酸血症患者),以及法国全国性调查中的1例OTC缺乏症患者。尽管这个回顾性系列并不能真正代表低蛋白饮食与精氨酸、苯甲酸钠和苯丁酸钠联合使用的现代治疗方法,但显然所有尿素循环障碍的长期预后仍然不容乐观。我们强调了这些疾病新生儿型的严重性,尤其是OTC缺乏症男性患者。基于这一证据,我们的政策是不治疗新生儿期如此严重的患者,因为他们无论如何都会在2至3天内自然死亡。目前,我们仅有3例新生儿瓜氨酸血症患者,年龄分别为1岁、6岁和10岁,他们目前情况良好。其中1例在5岁时成功接受了肝移植。另1例移植患者在术后阶段死亡。我们强调了精氨琥珀酸尿症出人意料的严重性,没有1例患者情况良好。这是一个相当令人惊讶的发现,因为这种疾病易于管理,在补充精氨酸治疗时很少出现高氨血症反复发作。这一考虑表明应扩大这种疾病原位肝移植的适应证。最后,最难确定适应证的是晚发型有症状的女性OTC缺乏症患者群体。在这最后一组患者中,尽管由于杂合子状态存在显著的残余活性,即使存在可变的X染色体失活,仍只有7名女孩在精神和神经方面正常。有趣的是,这7名女孩中有3名在不可逆神经损伤形成之前接受了肝移植。这3名女孩及其家人表示他们身体健康,感觉已治愈并享受正常生活。